Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Asati, Vivek; Anant, Arjun; Patel, Preeti; Kaur, Kamalpreet; Gupta, G D

Asati, Vivek; Anant, Arjun; Patel, Preeti; Kaur, Kamalpreet; Gupta, G D.

Afiliação

Asati V; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India. Electronic address: vivekasatipharma47@gmail.com.
Anant A; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Patel P; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Kaur K; Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.
Gupta GD; Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.

Eur J Med Chem ; 225: 113781, 2021 Dec 05.

Article em En | MEDLINE | ID: mdl-34438126

Assuntos

Antineoplásicos/farmacologia; Neoplasias/tratamento farmacológico; Pirazóis/farmacologia; Pirimidinas/farmacologia; Antineoplásicos/química; Proliferação de Células/efeitos dos fármacos; Humanos; Estrutura Molecular; Neoplasias/metabolismo; Neoplasias/patologia; Pirazóis/química; Pirimidinas/química

Palavras-chave

Anticancer; Kinase; Pyrazolo-pyrimidines; SAR; Targets

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google